Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
FamiCord AG (V3V.DE)
EUR3.24
+0.12 (+3.85%)
DE XETRA Healthcare Medical - Care Facilities
Address
Perlickstrasse 5 4103
Leipzig, DE
Leipzig, DE
CEO
Jakub Julian Baran
Website
famicord.com
IPO
2007-03-27
ISIN DE000A0BL849
Also trades on
Deutsche Börse · V3V.DE (EUR)
Other OTC · VTIAF (USD)
Description
VITA 34 AG is dedicated to the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its operations span Germany, Spain, and global markets. The company actively develops a range of advanced therapeutic solutions, including cell and gene therapies, specialized cell therapeutic procedures, cryopreservation of a patient's own immune cells, and CAR-T cell technology. Furthermore, VITA 34 manufactures advanced therapy medicinal products (ATMPs) based on mesenchymal stem cells for experimental applications by specialized medical institutions. It also preserves stem cells from perinatal tissues and adult body fat, and provides contract manufacturing for pharmaceutical intermediates. Founded in 1997, VITA 34 AG is headquartered in Leipzig, Germany.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR3.24
+0.12 (+3.85%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1.3K
Beta
0.63
Float Shares
6.32M
Free Float %
36.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.28% | -1.00% | -10.59% | -23.65% | -24.38% | -34.38% | -2.22% | -42.13% | -74.47% | -10.59% | -68.14% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3.24
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.21
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+7.3% Q1'26: -2.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+48.6% ★ Q1'26: +75.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-7.6% Q1'26: -1.1% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-4.0% Q1'26: +0.9% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-20.6%
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +30.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×4.94× Q1'26: 29.68× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2007 actual |
Dec 2008 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.43M
est: 15.15M (+1.8%)
|
14.96M
est: 15.73M (-4.9%)
|
16.96M
est: 17.73M (-4.3%)
|
16.00M
est: 16.84M (-5.0%)
|
13.60M
est: 13.79M (-1.4%)
|
13.55M
est: 14.13M (-4.1%)
|
13.79M
est: 14.20M (-2.9%)
|
14.17M
est: 15.03M (-5.7%)
|
16.29M
est: 15.90M (+2.5%)
|
19.19M
est: 19.30M (-0.6%)
|
20.41M
est: 20.70M (-1.4%)
|
20.25M
est: 20.20M (+0.2%)
|
20.07M
est: 20.70M (-3.0%)
|
28.42M
est: 22.10M (+28.6%)
|
68.94M
est: 67.00M (+2.9%)
|
77.06M
est: 78.82M (-2.2%)
|
82.18M
est: 82.00M (+0.2%)
|
88.17M
est: 88.20M (0.0%)
|
85.00M
85.00M – 85.00M
-3.6% YoY
|
88.40M
88.40M – 88.40M
+4.0% YoY
|
91.90M
91.90M – 91.90M
+4.0% YoY
|
| EBITDA |
113.0K
est: 263.3K (-57.1%)
|
-1.71M
est: 268.0K (-736.6%)
|
1.90M
est: 301.9K (+527.6%)
|
638.0K
est: 286.8K (+122.4%)
|
414.0K
est: 235.0K (+76.2%)
|
2.66M
est: 240.7K (+1,004.5%)
|
2.22M
est: 2.47M (-10.1%)
|
136.0K
est: 3.11M (-95.6%)
|
2.36M
est: 4.37M (-45.9%)
|
1.89M
est: 335.4K (+464.8%)
|
4.12M
est: 1.38M (+198.2%)
|
5.48M
est: 3.03M (+80.7%)
|
5.01M
est: 5.48M (-8.5%)
|
949.0K
est: 5.85M (-83.8%)
|
-18.34M
est: 6.62M (-377.0%)
|
5.81M
est: -1.71M (+438.7%)
|
-443.0K
est: 3.14M (-114.1%)
|
4.76M
est: -1.92M (+348.1%)
|
-1.85M
-1.85M – -1.85M
+3.6% YoY
|
-1.92M
-1.92M – -1.92M
-4.0% YoY
|
-2.00M
-2.00M – -2.00M
-4.0% YoY
|
| EBIT |
-291.0K
est: -1.62M (+82.1%)
|
-1.80M
est: -1.65M (-8.9%)
|
951.0K
est: -1.86M (+151.0%)
|
-335.0K
est: -1.77M (+81.1%)
|
-742.0K
est: -1.45M (+48.8%)
|
1.47M
est: -1.49M (+198.9%)
|
1.45M
est: 1.48M (-1.7%)
|
1.71M
est: 1.81M (-5.4%)
|
687.0K
est: 1.71M (-59.8%)
|
141.0K
est: -2.07M (+106.8%)
|
2.63M
est: 151.2K (+1,639.8%)
|
2.34M
est: 2.62M (-10.8%)
|
2.05M
est: 3.28M (-37.7%)
|
-3.09M
est: 3.51M (-188.3%)
|
-27.02M
est: 3.97M (-781.1%)
|
-2.76M
est: -10.69M (+74.2%)
|
-9.12M
est: -11.12M (+18.0%)
|
-3.52M
est: -11.96M (+70.6%)
|
-11.52M
-11.52M – -11.52M
+3.6% YoY
|
-11.99M
-11.99M – -11.99M
-4.0% YoY
|
-12.46M
-12.46M – -12.46M
-4.0% YoY
|
| Net Income |
-1.19M
est: -10.44M (+88.7%)
|
-1.71M
est: -12.73M (+86.6%)
|
349.0K
est: 2.24M (-84.4%)
|
1.19M
est: 5.51M (-78.4%)
|
-579.0K
est: -3.44M (+83.2%)
|
838.0K
est: 2.75M (-69.6%)
|
1.10M
est: 844.2K (+30.3%)
|
1.98M
est: 1.18M (+67.9%)
|
408.0K
est: 2.10M (-80.6%)
|
-322.0K
est: -174.3K (-84.7%)
|
828.0K
est: -346.4K (+339.0%)
|
1.35M
est: 824.0K (+63.8%)
|
1.45M
est: 1.35M (+7.3%)
|
-3.93M
est: 1.44M (-372.1%)
|
-27.39M
est: -23.60M (-16.0%)
|
-1.87M
est: -97.8K (-1,806.4%)
|
-12.14M
est: -871.6K (-1,292.4%)
|
-6.30M
est: 1.22M (-616.5%)
|
174.3K
174.3K – 174.3K
-85.7% YoY
|
1.05M
1.05M – 1.05M
+500.0% YoY
|
2.27M
2.27M – 2.27M
+116.7% YoY
|
| SGA |
11.25M
est: 3.40M (+230.9%)
|
12.58M
est: 3.46M (+263.6%)
|
10.29M
est: 13.16M (-21.8%)
|
9.90M
est: 3.70M (+167.4%)
|
4.18M
est: 7.85M (-46.7%)
|
3.31M
est: 3.11M (+6.6%)
|
3.51M
est: 7.28M (-51.8%)
|
4.42M
est: 7.61M (-41.9%)
|
4.64M
est: 9.29M (-50.1%)
|
5.41M
est: 4.33M (+25.1%)
|
5.15M
est: 10.86M (-52.6%)
|
4.81M
est: 9.30M (-48.2%)
|
5.03M
est: 9.12M (-44.9%)
|
9.38M
est: 9.74M (-3.7%)
|
14.02M
est: 11.02M (+27.2%)
|
13.52M
est: 22.23M (-39.2%)
|
13.32M
est: 23.12M (-42.4%)
|
47.52M
est: 24.87M (+91.1%)
|
23.97M
23.97M – 23.97M
-3.6% YoY
|
24.93M
24.93M – 24.93M
+4.0% YoY
|
25.92M
25.92M – 25.92M
+4.0% YoY
|
| EPS |
-0.46
est: -0.60 (+23.2%)
|
-0.63
est: -0.73 (+13.3%)
|
0.18
est: 0.13 (+41.0%)
|
0.47
est: 0.31 (+49.6%)
|
-0.20
est: -0.20 (-1.8%)
|
0.27
est: 0.16 (+71.8%)
|
0.35
est: 0.32 (+9.7%)
|
0.65
est: 0.33 (+97.4%)
|
0.14
est: 0.12 (+20.0%)
|
-0.09
est: -0.01 (-807.0%)
|
0.20
est: 0.45 (-55.1%)
|
0.33
est: 0.34 (-2.9%)
|
0.35
est: 0.61 (-42.6%)
|
-0.67
est: 0.34 (-297.1%)
|
-1.73
est: -0.50 (-246.0%)
|
-0.12
est: -0.01 (-2,038.3%)
|
-0.70
est: -0.05 (-1,300.0%)
|
-0.36
est: 0.07 (-614.3%)
|
0.01
0.01 – 0.01
-85.7% YoY
|
0.06
0.06 – 0.06
+500.0% YoY
|
0.13
0.13 – 0.13
+116.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.30M
OE per share TTM
0.14
Owner's Yield
2.65%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
50.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-4.5K
Shares Outstanding
17.43M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jakub Julian Baran | Chairman of the Management Board & Chief Executive Officer | 437.0K | male |
| Tomasz Franciszek Baran | Vice President of the Management Board & CMO | 307.8K | male |
| Thomas Pfaadt | Chief Financial Officer & Member of Management Board | 168.4K | male |
| Conelia Wittke-Kothe | CCO & Member of Management Board | — | — |
| Santiago Luengo | Managing Director of Secuvita | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for V3V.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
